These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23242192)

  • 1. A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial.
    Guédon-Moreau L; Lacroix D; Sadoul N; Clémenty J; Kouakam C; Hermida JS; Aliot E; Boursier M; Bizeau O; Kacet S;
    Eur Heart J; 2013 Feb; 34(8):605-14. PubMed ID: 23242192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of remote monitoring vs. ambulatory follow-ups of implanted cardioverter defibrillators in the randomized ECOST study.
    Guédon-Moreau L; Lacroix D; Sadoul N; Clémenty J; Kouakam C; Hermida JS; Aliot E; Kacet S;
    Europace; 2014 Aug; 16(8):1181-8. PubMed ID: 24614572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased delivery of inappropriate shocks achieved by remote monitoring of ICD: a substudy of the ECOST trial.
    Guédon-Moreau L; Kouakam C; Klug D; Marquié C; Brigadeau F; Boulé S; Blangy H; Lacroix D; Clémenty J; Sadoul N; Kacet S
    J Cardiovasc Electrophysiol; 2014 Jul; 25(7):763-70. PubMed ID: 24602062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The benefits of remote monitoring in long-term care for patients with implantable cardioverter-defibrillators.
    Ošmera O; Bulava A
    Neuro Endocrinol Lett; 2014; 35 Suppl 1():40-8. PubMed ID: 25433353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily remote monitoring of implantable cardioverter-defibrillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST).
    Hindricks G; Varma N; Kacet S; Lewalter T; Søgaard P; Guédon-Moreau L; Proff J; Gerds TA; Anker SD; Torp-Pedersen C
    Eur Heart J; 2017 Jun; 38(22):1749-1755. PubMed ID: 29688304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote monitoring of patients with implantable cardioverter-defibrillators: can results from large clinical trials be transposed to clinical practice?
    Morichau-Beauchant T; Boulé S; Guédon-Moreau L; Finat L; Botcherby EJ; Périer MC; Salleron J; Guibout C; Marquié C; Klug D; Kouakam C; Wissocque L; Brigadeau F; Lacroix D; Kacet S
    Arch Cardiovasc Dis; 2014 Dec; 107(12):664-71. PubMed ID: 25241223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring.
    Heidbuchel H; Hindricks G; Broadhurst P; Van Erven L; Fernandez-Lozano I; Rivero-Ayerza M; Malinowski K; Marek A; Romero Garrido RF; Löscher S; Beeton I; Garcia E; Cross S; Vijgen J; Koivisto UM; Peinado R; Smala A; Annemans L
    Eur Heart J; 2015 Jan; 36(3):158-69. PubMed ID: 25179766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial).
    Mabo P; Victor F; Bazin P; Ahres S; Babuty D; Da Costa A; Binet D; Daubert JC;
    Eur Heart J; 2012 May; 33(9):1105-11. PubMed ID: 22127418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety and efficacy of classic ambulatory implantable cardioverter-defibrillator and resynchronisation systems follow-up compared to telemetric follow-up].
    Lelakowski J; Rydlewska A; Piekarz J; Lelakowska-Pieła M; Pudło J
    Pol Merkur Lekarski; 2016 Mar; 40(237):153-9. PubMed ID: 27088195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial.
    Varma N; Michalski J; Epstein AE; Schweikert R
    Circ Arrhythm Electrophysiol; 2010 Oct; 3(5):428-36. PubMed ID: 20716717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial.
    Gasparini M; Proclemer A; Klersy C; Kloppe A; Lunati M; Ferrer JB; Hersi A; Gulaj M; Wijfels MC; Santi E; Manotta L; Arenal A
    JAMA; 2013 May; 309(18):1903-11. PubMed ID: 23652522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial.
    Hindricks G; Elsner C; Piorkowski C; Taborsky M; Geller JC; Schumacher B; Bytesnik J; Kottkamp H
    Eur Heart J; 2014 Jan; 35(2):98-105. PubMed ID: 23868932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE).
    García-Fernández FJ; Osca Asensi J; Romero R; Fernández Lozano I; Larrazabal JM; Martínez Ferrer J; Ortiz R; Pombo M; Tornés FJ; Moradi Kolbolandi M
    Eur Heart J; 2019 Jun; 40(23):1837-1846. PubMed ID: 30793735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The benefits of a remote monitoring system in longterm follow up of patients with implantable cardioverter  defibrillators].
    Ošmera O; Bulava A
    Vnitr Lek; 2013 Apr; 59(4):269-76. PubMed ID: 23711052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automatic remote monitoring utilizing daily transmissions: transmission reliability and implantable cardioverter defibrillator battery longevity in the TRUST trial.
    Varma N; Love CJ; Schweikert R; Moll P; Michalski J; Epstein AE;
    Europace; 2018 Apr; 20(4):622-628. PubMed ID: 29016878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare Utilization and Expenditures Associated With Appropriate and Inappropriate Implantable Defibrillator Shocks.
    Turakhia MP; Zweibel S; Swain AL; Mollenkopf SA; Reynolds MR
    Circ Cardiovasc Qual Outcomes; 2017 Feb; 10(2):. PubMed ID: 28196927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study.
    Varma N
    Am Heart J; 2007 Dec; 154(6):1029-34. PubMed ID: 18035071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Automatic Wireless Remote Monitoring Immediately Following ICD Implant: The Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) Trial.
    Varma N; Epstein AE; Schweikert R; Michalski J; Love CJ;
    J Cardiovasc Electrophysiol; 2016 Mar; 27(3):321-6. PubMed ID: 26661687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.